Statement: the primary trial and the secondary trial use completely different drugs and techniques for their interventions.
Primary_evidence: INTERVENTION 1:    Fulvestrant + Anastrozole   Fulvestrant 250 mg Loading Dose Regimen + Anastrozole 1 mg INTERVENTION 2:    Anastrozole Anastrozole 1 mg
Secondary_evidence: INTERVENTION 1:    Prone to Supine MRI Evaluated by Radiologist A   Radiologist A, number of participants successfully segmented INTERVENTION 2:    Prone to Supine MRI Evaluated by Radiologist B   Radiologist B, number of participants successfully segmented